Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Valeria Merz
Observed names:
Merz, Valeria,
V Merz,
V. Merz
Institutions:
University of Verona,
Ospedale Santa Chiara
Observed institutions:
University of Verona,
Ospedale Santa Chiara,
Fudan University Shanghai Cancer Center,
Azienda Ospedaliera Universitaria Integrata Verona,
Provincia Autonoma di Trento
ORCID:
0000-0002-2120-1923
Observed ORCID:
0000-0002-2120-1923
OpenAlex ID:
A5073612690
Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer
2021
·
Davide Melisi
, Do-Youn Oh
, et al.
·
Journal for ImmunoTherapy of Cancer
·
233
PDF
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer
2018
·
Carmine Carbone
, Geny Piro
, et al.
·
International Journal of Molecular Sciences
·
228
PDF
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
2019
·
Laura Maggino
, Giuseppe Malleo
, et al.
·
JAMA Surgery
·
153
PDF
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer
2023
·
Joris van de Haar
, Xuhui Ma
, et al.
·
Nature Medicine
·
96
PDF
An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients
2016
·
Geny Piro
, Carmine Carbone
, et al.
·
Clinical Cancer Research
·
92
PDF
Targeting KRAS: The Elephant in the Room of Epithelial Cancers
2021
·
Valeria Merz
, Marina Gaule
, et al.
·
Frontiers in Oncology
·
81
PDF
Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer
2019
·
Raffaela Santoro
, Marco Zanotto
, et al.
·
Molecular Cancer Therapeutics
·
64
PDF
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma
2017
·
Geny Piro
, Francesca Simionato
, et al.
·
OncoImmunology
·
59
PDF
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients
2017
·
Carmine Carbone
, Geny Piro
, et al.
·
Clinical Cancer Research
·
51
PDF
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling
2017
·
C Carbone
, G Piro
, et al.
·
International Journal of Obesity
·
46
PDF
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal–gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial
2020
·
Valeria Merz
, Camilla Zecchetto
, et al.
·
Therapeutic Advances in Medical Oncology
·
44
PDF
Pemigatinib, a Potent Inhibitor of FGFRs for the Treatment of Cholangiocarcinoma
2020
·
Valeria Merz
, Camilla Zecchetto
, et al.
·
Future Oncology
·
42
Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma
2023
·
Silvia Pietrobono
, Fabio Sabbadini
, et al.
·
Cancer Research
·
37
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients
2015
·
G Piro
, S Giacopuzzi
, et al.
·
British Journal of Cancer
·
37
PDF
NUT midline carcinoma: Current concepts and future perspectives of a novel tumour entity
2019
·
Massimiliano Salati
, Cinzia Baldessari
, et al.
·
Critical Reviews in Oncology/Hematology
·
36
Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine
2021
·
Federica Vernuccio
, Carlo Messina
, et al.
·
Diagnostics
·
34
PDF
Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer
2020
·
Valeria Merz
, Camilla Zecchetto
, et al.
·
Clinical Cancer Research
·
30
Adjuvant chemotherapy in resected bile duct cancer: A systematic review and meta-analysis of randomized trials
2019
·
Carlo Messina
, Valeria Merz
, et al.
·
Critical Reviews in Oncology/Hematology
·
26
Population pharmacokinetics and exposure–overall survival analysis of the transforming growth factor-β inhibitor galunisertib in patients with pancreatic cancer
2019
·
Ivelina Gueorguieva
, Josep Tabernero
, et al.
·
Cancer Chemotherapy and Pharmacology
·
23
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists
2020
·
Margaret Ottaviano
, Marcello Curvietto
, et al.
·
Journal for ImmunoTherapy of Cancer
·
20
PDF
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion
2022
·
Marina Gaule
, Camilla Pesoni
, et al.
·
JCO Precision Oncology
·
19
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma
2023
·
Letizia Procaccio
, Valeria Merz
, et al.
·
Cancer Medicine
·
18
PDF
Electronic Medical Record–Assisted Telephone Follow-Up of Breast Cancer Survivors During the COVID-19 Pandemic: A Single Institution Experience
2020
·
Valeria Merz
, Antonella Ferro
, et al.
·
JCO Oncology Practice
·
17
CCL3 predicts exceptional response to TGFβ inhibition in basal-like pancreatic cancer enriched in LIF-producing macrophages
2024
·
Silvia Pietrobono
, Monica Bertolini
, et al.
·
npj Precision Oncology
·
16
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial
2023
·
Davide Melisi
, Camilla Zecchetto
, et al.
·
European Journal of Cancer
·
14
PDF
Show more works
View as search
Works count:
125
Citation count:
1,654
H-index:
20
I10-index:
29
Year
Topic
Type